These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6142671)

  • 1. Desensitization for sulfasalazine skin rash.
    Purdy BH; Philips DM; Summers RW
    Ann Intern Med; 1984 Apr; 100(4):512-4. PubMed ID: 6142671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desensitization for sulfasalazine-induced skin rash in a patient with ulcerative colitis.
    Akahoshi K; Chijiiwa Y; Kabemura T; Okabe H; Akamine Y; Nawata H
    J Gastroenterol; 1994 Dec; 29(6):772-5. PubMed ID: 7874275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desensitization to sulfasalazine after hypersensitivity reactions in patients with inflammatory bowel disease.
    Korelitz BI; Present DH; Rubin PH; Fochios SE
    J Clin Gastroenterol; 1984 Feb; 6(1):27-31. PubMed ID: 6142067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desensitization of patients with inflammatory bowel disease to sulfasalazine.
    Taffet SL; Das KM
    Am J Med; 1982 Oct; 73(4):520-4. PubMed ID: 6127032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfasalazine pneumonitis.
    Averbuch M; Halpern Z; Hallak A; Topilsky M; Levo Y
    Am J Gastroenterol; 1985 May; 80(5):343-5. PubMed ID: 2859799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash.
    Bax DE; Amos RS
    Ann Rheum Dis; 1986 Feb; 45(2):139-40. PubMed ID: 2868699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfasalazine desensitization in children and adolescents with chronic inflammatory bowel disease.
    Tolia V
    Am J Gastroenterol; 1992 Aug; 87(8):1029-32. PubMed ID: 1353658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulphasalazine desensitization in a paediatric patient with juvenile chronic arthritis.
    Kümmerle-Deschner J; Dannecker G
    Acta Paediatr; 1995 Aug; 84(8):952-4. PubMed ID: 7488828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype.
    Das KM; Eastwood MA; McManus JP; Sircus W
    N Engl J Med; 1973 Sep; 289(10):491-5. PubMed ID: 4146729
    [No Abstract]   [Full Text] [Related]  

  • 10. Acetylator phenotype and serum levels of sulfapyridine in patients with inflammatory bowel disease.
    Sharp ME; Wallace SM; Hindmarsh KW; Brown MA
    Eur J Clin Pharmacol; 1981; 21(3):243-50. PubMed ID: 6119205
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pulmonary diffusing capacity disorder in nonspecific intestinal inflammations unexplainable by acetylation phenotype or treatment with sulfasalazine].
    Bures J; Horácek J; Tilser P; Fixa B; Komárková O; Tichý M; Zaydlar K; Král B
    Cas Lek Cesk; 1986 Jul; 125(29):905-9. PubMed ID: 2873894
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of sulfasalazine in the treatment of inflammatory bowel disease.
    Spector R
    J Iowa Med Soc; 1983 Jun; 73(6):230-4. PubMed ID: 6135735
    [No Abstract]   [Full Text] [Related]  

  • 13. Pulmonary infiltrates and skin pigmentation associated with sulfasalazine.
    Gabazza EC; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S; Matsumoto K; Kitagawa T; Yamamoto J
    Am J Gastroenterol; 1992 Nov; 87(11):1654-7. PubMed ID: 1359782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desensitization to sulphasalazine in patients with arthritis.
    Koski JM
    Clin Exp Rheumatol; 1993; 11(2):169-70. PubMed ID: 8099541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfasalazine intolerance. A retrospective survey of the reasons for discontinuing treatment with sulfasalazine in patients with chronic inflammatory bowel disease.
    Nielsen OH
    Scand J Gastroenterol; 1982 Apr; 17(3):389-93. PubMed ID: 6127793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary infiltration and eosinophilia associated with sulfasalazine therapy for ulcerative colitis: a case report and review of literature.
    Yamakado S; Yoshida Y; Yamada T; Kishida T; Kobayashi M; Nomura T
    Intern Med; 1992 Jan; 31(1):108-13. PubMed ID: 1348965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development.
    Peppercorn MA
    Ann Intern Med; 1984 Sep; 101(3):377-86. PubMed ID: 6147110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfasalazine lung. Desensitization to sulfasalazine and treatment with acrylic coated 5-ASA and azodisalicylate.
    Sullivan SN
    J Clin Gastroenterol; 1987 Aug; 9(4):461-3. PubMed ID: 2888803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatitis and pancreatic necrosis during sulfasalazine therapy.
    Faintuch J; Mott CB; Machado MC
    Int Surg; 1985; 70(3):271-2. PubMed ID: 2872181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Side effects of salicylazosulfapyridine therapy].
    Miller B
    Dtsch Med Wochenschr; 1980 Nov; 105(46):1596-7. PubMed ID: 6108200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.